|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.59 INR | +0.53% |
|
+2.98% | +52.40% |
| Market Cap | 1.85TCr 19Cr 17Cr 16Cr 14Cr 27Cr 28Cr 185.76Cr 73Cr 906.91Cr 72Cr 71Cr 3.12TCr | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.85TCr 19Cr 17Cr 16Cr 14Cr 27Cr 28Cr 185.75Cr 73Cr 906.86Cr 72Cr 71Cr 3.12TCr | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +0.53% | ||
| 1 week | +2.98% | ||
| Current month | +5.82% | ||
| 1 month | +24.78% | ||
| 3 months | +56.01% | ||
| 6 months | +62.40% | ||
| Current year | +52.40% |
| 1 week | 58.45 |  | 64.04 |
| 1 month | 49.1 | | 64.04 |
| Current year | 33.44 | | 64.04 |
| 1 year | 33.44 | | 65.07 |
| 3 years | 28.51 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CEO | Chief Executive Officer | 62 | 01/02/1992 |
Sanjay Suri
CEO | Chief Executive Officer | 57 | 01/07/2026 |
| Director of Finance/CFO | 59 | 03/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 01/02/1992 |
Ranjit Khattar
BRD | Director/Board Member | 66 | 12/08/2024 |
Sharad Jain
BRD | Director/Board Member | 64 | 27/08/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | +2.98% | -0.18% | +113.33% | 36Cr | |
| -2.48% | -6.58% | +44.40% | +156.81% | 1,05400Cr | |
| -1.52% | -5.01% | +61.87% | +58.79% | 62TCr | |
| -1.30% | -3.89% | +27.79% | +79.95% | 44TCr | |
| -1.12% | -1.45% | +27.34% | +22.20% | 32TCr | |
| -1.73% | -2.14% | +27.22% | +44.70% | 28TCr | |
| -1.95% | -13.92% | +15.96% | +19.76% | 26TCr | |
| -1.45% | -2.37% | -27.87% | -39.87% | 22TCr | |
| -1.44% | -3.49% | +19.60% | +56.20% | 19TCr | |
| -1.04% | -4.63% | +16.01% | +68.47% | 16TCr | |
| Average | -1.26% | -1.29% | +21.22% | +58.03% | 35.57TCr | |
| Weighted average by Cap. | -1.40% | -1.68% | +33.29% | +77.35% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.7TCr 18Cr 15Cr 14Cr 13Cr 25Cr 25Cr 170.7Cr 67Cr 833.37Cr 67Cr 65Cr 2.87TCr | 1.81TCr 19Cr 16Cr 15Cr 14Cr 27Cr 27Cr 181.7Cr 71Cr 887.07Cr 71Cr 69Cr 3.05TCr |
| Net income | 96Cr 1Cr 87.49L 80.88L 74.72L 1.41Cr 1.43Cr 9.64Cr 3.78Cr 47Cr 3.76Cr 3.68Cr 162.13Cr | 118.02Cr 1.23Cr 1.07Cr 99.26L 91.71L 1.73Cr 1.76Cr 12Cr 4.64Cr 58Cr 4.62Cr 4.51Cr 198.99Cr |
| Net Debt | 12Cr 12.55L 10.97L 10.14L 9L 17.64L 17.96L 1.21Cr 47.44L 5.9Cr 47.14L 46.1L 20Cr | -9L -9.66T -8.44T -7.8T -7.21T -13.58T -13.83T -93.08T -36.52T -5L -36.29T -35.49T -15.65L |
Employees
1,814
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | ₹62.59 | +0.53% | 6,14,461 |
| 13/26/13 | ₹62.26 | +1.73% | 10,07,167 |
| 10/26/10 | ₹61.20 | +0.38% | 7,58,896 |
| 09/26/09 | ₹60.97 | +3.43% | 6,97,427 |
| 08/26/08 | ₹58.95 | -3.61% | 6,50,060 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
